Register entry
Rafa Laboratories Ltd.
- Registered sites
- 1
- Drug products
- 4
- Live patents
- 0
- Countries
- 1
- Base
- Israel
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Rafa Laboratories Ltd. | JerusalemIsrael | Analytical testing, Labelling, Finished drug manufacture | 3004437307 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Atropine Injection, 2 mg | INJECTION | NDA |
| - | Atropine Sulfate Injection USP, 0.5 mg/0.7 mL | INJECTION | UNAPPROVED DRUG OTHER |
| - | Atropine Sulfate Injection USP, 1 mg/0.7 mL | INJECTION | UNAPPROVED DRUG OTHER |
| - | Midazolam Injection, 10 mg | INJECTION, SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.